芬舒雅对冠心病心绞痛微循环障碍的治疗作用

Therapeutic Effect of Fen Shu Ya on Coronary Heart Disease with Angina Pectoris and Microcirculatory Disturbance

芬舒雅是由桂枝、丹参等配伍精制的吸入型中药制剂。将其用于42例冠心病心绞痛患者的微循环障碍,并与使用速效救心丸的30例同类患者进行对照比较。结果发现:芬舒雅与速效救心丸对上述患者心绞痛及微循环障碍的总有效率分别为85.7%,92.9%和83.3%,73.3%,提示:芬舒雅是优于速效救心丸等临床常用药剂的新型制剂。

Fen Shu Ya(FSY) is a new type inhaled traditional medicine which was refined from Gui Zhi (Cassia twig) and Dan Shen (Salvia miltiorrhiza). Therapeutic effect of FSY on 42 Patients with coronary heart disease(CHD) within angina pectoris and microcirculatory disturbance were observed and compared on other 30 patients which was used Su Xiao Jiu Xin Wan(SXW). Results showed that the effective rate of relieving angina pectoris and improving microcirculatory disturbance were 85.7%, 92.9% after using FSY, and 83.3%, 73.3% after using SXW respectively. It suggest that the therapeutic effect of FSY on angina pectoris and microcirculatory disturbance was better than SXW.